• Latest Posts

Update: Fifth US Antibody Patent Owned by UK Biotech Upheld in Regeneron Battle

Finnish Genetics Study Provides Clues for Treating Type 2 Diabetes

Dutch and US Biotechs Team Up Against HPV-related Cancer

Biotech and Pharma Giants Make a Good Start to Phase II Trial for Skin Cancer

Checkpoint Inhibitor from Regeneron and Sanofi gets Priority After Breakup


Novartis Tops Ophthalmology Blockbuster Eylea in Phase III Trials

Get Ready for One of the Biggest New Drug Approvals of the Year

Which European Blockbusters Topped the Charts in 2016?

The 8 Biggest Biotech Medical Fails of 2016 in Europe

UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug

18,000 Patients Enrolled for One of the Most Comprehensive Trials Against Cholesterol